Full-Time

Territory Manager

Posted on 8/25/2025

Element Science

Element Science

51-200 employees

Wearable defibrillator for sudden cardiac arrest

Compensation Overview

$100k - $125k/yr

+ Uncapped Commission Plan + Stock Options

No H1B Sponsorship

San Francisco, CA, USA

In Person

Must have a reliable automobile for travel; travel up to 60% of the time, including overnight stays.

Category
Sales & Account Management (3)
, ,
Required Skills
Sales
Requirements
  • Bachelor’s degree required; master’s degree preferred.
  • 5+ years of B2B sales experience with cardiology and/or electrophysiology call points.
  • Demonstrate the ability to identify customer’s needs and to deliver or adjust expectations.
  • Strong organizational, analytical, and problem-solving abilities.
  • Ability to establish new market strategies to achieve sales quotas.
  • Strong foundational sales skills.
  • Ability to navigate complex IDN and hospital networks.
  • Must possess a reliable automobile for work-related travel.
  • Clean driving record with valid state’s driver’s license.
  • Willingness and ability to travel up to 60% of the time, including overnight stays, evenings, and weekends, as necessary.
Responsibilities
  • Optimize sales and profitability of the Jewel product across targeted markets.
  • Develops sales contacts and extends marketing reach by attending local, regional, and national trade shows/conferences.
  • Drive sales growth through the strategic development and utilization of diverse sales channels.
  • Achievement of sales quotas and key performance indicators.
  • Establishes industry networks to enhance business presence and brand visibility.
  • Maintains and develops client contacts at all levels within customer organizations and clinics.
  • Develops clear, achievable strategies, objectives, and tactical plans grounded in segmentation, customer-centricity/needs, and market dynamics.
  • Deliver clear and succinct feedback to operational partners to enhance the customer experience.
Desired Qualifications
  • Master’s degree preferred.
  • Experience with cardiology and/or electrophysiology call points.

Element Science creates medical devices to prevent sudden cardiac arrest. Its flagship product, Jewel, is a wearable external defibrillator intended to provide around-the-clock protection by monitoring the heart and delivering a life-saving shock when needed. Jewel is not yet commercially available in the U.S. This device works by continuously monitoring cardiac rhythm and, if a dangerous rhythm is detected, delivering a controlled electrical defibrillation; it is designed for use by at-risk individuals under medical guidance. The company differentiates itself by focusing on a wearable, user-friendly defibrillator and by prioritizing workforce diversity, equity, inclusion, and belonging (DEIB), as well as growth through team expansion. Element Science aims to bring Jewel to market, work with healthcare providers and insurers, increase accessibility for patients at risk of sudden cardiac arrest, and grow its market share while reducing deaths from cardiac events.

Company Size

51-200

Company Stage

Series C

Total Funding

$183.1M

Headquarters

San Francisco, California

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • 500,000+ addressable patient market in US and Europe with temporary cardiac risk.
  • Lee Smith Jr. Head of Commercial brings 20 years medical device launch expertise.
  • Reimbursement discussions strengthened by clinical evidence and regulatory clearances achieved.

What critics are saying

  • ZOLL LifeVest dominates market with established payer relationships and physician preference.
  • CMS reimbursement delays post-FDA approval burn cash and erode investor confidence.
  • Apple Watch AFib detection and ECG features reduce dedicated P-WCD demand.

What makes Element Science unique

  • Jewel patch form factor eliminates garment-based WCD comfort and compliance barriers.
  • FDA approval and CE/UKCA marks enable immediate EU and US commercialization.
  • IDE Study validated 305-patient clinical efficacy with zero serious adverse events.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Stock Options

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

FSA (Flexible Spending Accounts)

HSA (Health Savings Account)

Employee Assistance Program through PEO

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

-3%

2 year growth

1%
Business Wire
Mar 24th, 2026
Element Science named one of the world's most innovative companies by Fast Company

Element Science, a San Francisco-based health technology company, has been named to Fast Company's World's Most Innovative Companies of 2026 list. The company developed the Jewel Patch Wearable Cardioverter Defibrillator, which monitors and protects cardiovascular patients from sudden cardiac arrest. The Jewel Patch-WCD received FDA approval in April 2025 and European CE mark certification in January 2024. The device is water-resistant, discreet and requires no daily maintenance, distinguishing it as the only wearable cardioverter defibrillator that can be worn whilst showering. The product is currently in early commercial launch across select US states, targeting over 500,000 patients in the US and Europe at temporary risk of sudden cardiac arrest. Element Science's investors include Third Rock Ventures, Google Ventures and Deerfield Management.

Valdosta Daily Times
Jul 8th, 2024
Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel(R) Patch Wearable Cardioverter Defibrillator

Element Science, an innovative health technology company pioneering a digital wearable platform that monitors and protects high-risk cardiovascular patients, announces that its Jewel(R) Wearable Patch Cardioverter Defibrillator (Jewel) has received the prestigious Red Dot Design Award.

Business Wire
May 15th, 2024
Element Science Appoints Lee Smith, Jr. As The Company'S First Head Of Commercial

With nearly 20 years of successful leadership experience in sales strategy, commercial operations, and customer success, Mr. Smith will be instrumental in driving the launch and expansion of Element Science's Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) in globally markets. (Photo: Business Wire)With nearly 20 years of successful leadership experience in sales strategy, commercial operations, and customer success, Mr. Smith will be instrumental in driving the launch and expansion of Element Science's Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) in globally markets. (Photo: Business Wire)SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company developing a pioneering digital wearable platform for high-risk cardiovascular patients, announced the appointment of Lee Smith Jr. as the company's first Head of Commercial

Business Wire
Jan 25th, 2024
Element Science Receives Ce Mark Ukca Mark For The Jewel® Patch-Wearable Cardioverter Defibrillator

Element Science Receives CE Mark & UKCA Mark for the Jewel® Patch-Wearable Cardioverter Defibrillator First of its kind life-saving technology receives CE Mark and UKCA Mark, paving the way for enhanced protection of patients with elevated risk of sudden cardiac arrest. (Photo: Business Wire)Element Science Receives CE Mark & UKCA Mark for the Jewel® Patch-Wearable Cardioverter Defibrillator First of its kind life-saving technology receives CE Mark and UKCA Mark, paving the way for enhanced protection of patients with elevated risk of sudden cardiac arrest. (Photo: Business Wire)SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, announced that it has received the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking for its novel Patch Wearable Cardioverter Defibrillator (P-WCD) from its Notified Body, the BSI Group.The Jewel P-WCD was designed to address limitations with traditional garment-based WCDs. While these garment-based WCDs have demonstrated the ability to treat sudden cardiac arrest (SCA), a leading cause of death in the United States and in Europe, challenges related to patient comfort and compliance have resulted in avoidable deaths and limited their widespread adoption.The effectiveness of the Jewel defibrillator was confirmed in the Jewel EP Lab Study, conducted in Prague, Czech Republic, in which 16 patients experiencing ventricular arrhythmias were successfully converted to a normal heart rhythm after a single therapeutic shock. The Jewel IDE Study, a pivotal study of 305 patients presented at the American Heart Association’s 2023 Annual Scientific Sessions demonstrated significant patient compliance and protected time resulting in a high number of successful patient saves and no deaths or serious adverse events related to the device (www.ElementScience.com/ide-study/ ).Dr. Uday N

Business Wire
Oct 26th, 2022
Element Science Appoints Trish Howell As Chief Operating Officer | Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced that Trish Howell has been appointed as the Company’s new Chief Operating Officer, effective October 17, 2022. “ Ms. Howell is a transformational leader who has excelled in her positions prior to joining Element Science. As an innovative and seasoned executive, she expands the capabilities of our leadership team at an inflection point of our growth. Her experience in building successful commercial operations at medical device companies gives her a critically valuable perspective that will be an indispensable asset as we look forward to commercializing our technology and expanding our pipeline of products,” said Uday N. Kumar, MD, Founder, President and CEO

INACTIVE